UNSPSC 51422353: Methylprednisolone aceponate

This classification denotes a therapeutic glucocorticoid with the molecular formula C27H36O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ET54W9J4U2, chemically known as 11beta,17,21-trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione, 21-acetate 17-propionate but more generally known as methylprednisolone aceponate, which bears US NIH Compound Identifier 63019. European Medicines Agency schedules Methylprednisolone aceponate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08873MIG.

UNSPSC 51422353 Methylprednisolone aceponate is a Commodity code, but the recent state and local opportunities posted under it show no procurement activity for this specific pharmaceutical product. The two most recent opportunities tagged to this code—Seminole County's competitive bidding for naloxone and drug deactivation systems, and the Texas Health and Human Services Commission's request for information on direct-to-manufacturer prescription programs—fall outside the scope of methylprednisolone aceponate procurement and suggest potential tagging misalignment in the underlying procurement database. State and local health departments and HHS agencies would be the natural issuing bodies for pharmaceutical purchases under this code, but no concrete solicitations for methylprednisolone aceponate or related topical corticosteroids have surfaced in recent postings.

No recent state and local opportunities for methylprednisolone aceponate procurement are supported by the source material. The code shows minimal current procurement activity at the state and local level, with no geographic concentration, representative RFPs or IFBs, or identifiable demand signals that would inform a pursue decision.